Auna (NYSE:AUNA) President Acquires $97,746.60 in Stock

Auna S.A. (NYSE:AUNA) President Leon Jesus Zamora acquired 23,273 shares of the company’s stock in a transaction dated Wednesday, May 27th. The stock was purchased at an average cost of $4.20 per share, for a total transaction of $97,746.60. Following the purchase, the president directly owned 62,710 shares in the company, valued at approximately $263,382. This represents a 59.01% increase in their position. The purchase was disclosed in a filing with the SEC, which is available through this link.

Leon Jesus Zamora also recently made the following trade(s):

• On Tuesday, May 26th, Leon Jesus Zamora acquired 8,727 shares of Auna stock. The stock was purchased at an average cost of $4.24 per share, for a total transaction of $37,002.48.

Auna Price Performance

Shares of AUNA traded up $0.04 during midday trading on Thursday, reaching $4.20. The stock had a trading volume of 333,444 shares, compared to its average volume of 352,403. Auna S.A. has a 52 week low of $4.13 and a 52 week high of $6.85. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.09 and a quick ratio of 1.00. The firm’s 50 day moving average price is $5.25 and its 200-day moving average price is $5.02. The company has a market capitalization of $310.47 million, a P/E ratio of 16.14 and a beta of 1.03.

Auna (NYSE:AUNA) last posted its quarterly earnings data on Friday, May 15th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.14). Auna had a return on equity of 16.25% and a net margin of 1.53%.The firm had revenue of $336.84 million during the quarter, compared to the consensus estimate of $320.54 million. On average, analysts forecast that Auna S.A. will post 0.85 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on AUNA. JPMorgan Chase & Co. dropped their price objective on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Tuesday. Weiss Ratings restated a “sell (d)” rating on shares of Auna in a report on Friday, March 27th. Wall Street Zen cut Auna from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 16th. Finally, Zacks Research cut Auna from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 31st. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $6.97.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of AUNA. Renaissance Technologies LLC raised its position in Auna by 487.7% during the first quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock valued at $3,683,000 after buying an additional 554,707 shares during the period. Marshall Wace LLP raised its position in Auna by 391.0% during the fourth quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock valued at $802,000 after buying an additional 129,799 shares during the period. Lazard Asset Management LLC acquired a new position in Auna during the first quarter valued at $557,000. Hsbc Holdings PLC acquired a new position in Auna during the first quarter valued at $324,000. Finally, Arrowstreet Capital Limited Partnership acquired a new position in Auna during the first quarter valued at $316,000.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.